Targeting AR positive prostate cancer cells by the novel P300/CBP oral available PROTAC degrader

被引：0
|
作者：
Luo, Jie
Prolia, Abhijit
Qiao, Yuanyuan
Tian, Jean
Mannan, Rahul
Mahapatra, Somnath
Chen, Zhixiang
Seri, Rithvik
Wang, Shaomeng
Chinnaiyan, Arul
机构：
来源：
CANCER RESEARCH | 2023年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6048
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6048
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting the p300/CBP Axis in Lethal Prostate Cancer
    Welti, Jonathan
    Sharp, Adam
    Brooks, Nigel
    Yuan, Wei
    McNair, Christopher
    Chand, Saswati N.
    Pal, Abhijit
    Figueiredo, Ines
    Riisnaes, Ruth
    Gurel, Bora
    Rekowski, Jan
    Bogdan, Denisa
    West, William
    Young, Barbara
    Raja, Meera
    Prosser, Amy
    Lane, Jordan
    Thomson, Stuart
    Worthington, Jenny
    Onions, Stuart
    Shannon, Jonathan
    Paoletta, Silvia
    Brown, Richard
    Smyth, Don
    Harbottle, Gareth W.
    Gil, Veronica S.
    Miranda, Susana
    Crespo, Mateus
    Ferreira, Ana
    Pereira, Rita
    Tunariu, Nina
    Carreira, Suzanne
    Neeb, Antje J.
    Ning, Jian
    Swain, Amanda
    Taddei, David
    Schiewer, Matthew J.
    Knudsen, Karen E.
    Pegg, Neil
    de Bono, Johann S.
    CANCER DISCOVERY, 2021, 11 (05) : 1118 - 1137
  • [2] CBP/p300 Degrader: A Promising Therapeutic Strategy for Treatment of Prostate Cancer and Beyond
    Hu, Jiankang
    Xu, Yong
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (07) : 5272 - 5274
  • [3] p300 and CBP targeting in castration therapy resistant prostate cancer
    Furlan, Tobias
    Sampson, Natalie
    Santer, Frederic R.
    Culig, Zoran
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
    Chen, Zhixiang
    Wang, Mi
    Wu, Dimin
    Zhao, Lijie
    Metwally, Hoda
    Jiang, Wei
    Wang, Yu
    Bai, Longchuan
    Mceachern, Donna
    Luo, Jie
    Wang, Meilin
    Li, Qiuxia
    Matvekas, Aleksas
    Wen, Bo
    Sun, Duxin
    Chinnaiyan, Arul M.
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (07) : 5351 - 5372
  • [5] AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer
    Sardar, Sumaira
    McNair, Christopher M.
    Ravindranath, Lakshmi
    Chand, Saswati N.
    Yuan, Wei
    Bogdan, Denisa
    Welti, Jon
    Sharp, Adam
    Ryan, Natalie K.
    Knudsen, Liam A.
    Schiewer, Matthew J.
    DeArment, Elise G.
    Janas, Thomas
    Su, Xiaofeng A.
    Butler, Lisa M.
    de Bono, Johann S.
    Frese, Kris
    Brooks, Nigel
    Pegg, Neil
    Knudsen, Karen E.
    Shafi, Ayesha A.
    ONCOGENE, 2024, : 3197 - 3213
  • [6] Targeting CBP/p300 and its downstream transcriptional machinery in advanced prostate cancer
    Sardar, Sumaira
    Ravindranath, Lakshmi
    McNair, Christopher
    Chand, Saswati
    Yuan, Wei
    Bogdan, Denisa
    Welti, Jon
    Sharp, Adam
    Schiewer, Matthew
    Butler, Lisa
    de Bono, Johann
    Frese, Kris
    Brooks, Nigel
    Pegg, Neil
    Knudsen, Karen
    Shafi, Ayesha
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Targeting the CBP/p300 axis in lethal prostate cancer impacts DNA repair
    Sardar, Sumaira
    Ravindranath, Lakshmi
    McNair, Christopher
    Chand, Saswati N.
    Yuan, Wei
    Bogdan, Denisa
    Welti, Jonathan
    Sharp, Adam
    Schiewer, Matthew
    Butler, Lisa
    de Bono, Johann
    Frese, Kris
    Brooks, Nigel
    Pegg, Neil
    Knudsen, Karen
    Shafi, Ayesha A.
    CANCER RESEARCH, 2023, 84 (06)
  • [8] Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma
    Chang, Qi
    Li, Jiayi
    Deng, Yue
    Zhou, Ruilin
    Wang, Bingwei
    Wang, Yujie
    Zhang, Mingming
    Huang, Xun
    Li, Yingxia
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (04) : 2466 - 2486
  • [9] Targeting cancer with selective cbp/p300 bromodomain inhibitors
    Jaleel, Mahaboobi
    Senaiar, Ramesh S.
    Abbineni, Chandrasekhar
    Renukappa, Girish A.
    Mukherjee, Subhendu
    Marappan, Sivapriya
    Samiulla, D. S.
    Aravind, A. B.
    Kumar, Naveen R.
    Reddy, Venkata Siva N.
    Babu, Asha
    Srinivas, Akhila P.
    Yadlapalli, Prasad
    Tgore, Suraj
    Raghavendra, N. R.
    Naik, Chandranath D.
    Giri, Sanjeev
    Antony, Thomas
    Nellore, Kavitha
    Chelur, Shekar
    Daginakatte, Girish
    Ravanti, laura
    Myllymaki, Mikko
    Wohlfahrt, Gerd
    Mattila, Elina
    Karlsson, Stefan
    Bjorkman, Mari
    Riikonen, Reetta
    Ikonen, Tarja
    Leimu, Laura
    Malmstrom, Chira
    Korjamo, Timo
    Moilanen, Anu
    Ramachandra, Murali
    Samajdar, Susanta
    CANCER RESEARCH, 2020, 80 (16)
  • [10] The coactivators CBP and p300 in androgen independent prostate cancer
    Debes, JD
    Culig, Z
    Tindall, DJ
    HORMONAL CARCINOGENESIS IV, 2005, : 494 - 500
12345